NewsUK Cannabis Lawyers Memery Crystal Bought By City Firm...

UK Cannabis Lawyers Memery Crystal Bought By City Firm For £30m

-

RESPECTED UK cannabis law firm Memery Crystal has been bought by City firm RBG Holdings for £30m. 

Memery Crystal handled the legal aspects of the flotation of the first cannabis company – MGC Pharmaceuticals – on to the London Stock Exchange, in February this year.

Its Managing Director Nick Davis is well-known in the industry with the firm currently acting for a number of cannabis companies looking at London floats and fundraising.

Mr Davis will remain with the firm which will retain its own brand identity and separate offices. RBG Holdings plc was previously known as Rosenblatt and is listed on the Alternative Investment Market. 

Nick Davis

Nicola Foulston, chief executive of RBG Holdings, said: “Memery Crystal is an excellent addition to the group both culturally and operationally. Both businesses are entrepreneurial in nature.”

Memery Crystal has 29 partners and the deal involves RBG paying £12m in cash, £11.2m in shares and £6.8m in deferred shares, reports The Times. 

As well as cannabis Memery Crystal has a strong presence across the capital markets, private wealth, finance, real estate, technology retail, leisure and natural resources.



Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Thought Leaders Acquisition Of mellow Set To Accelerate Growth Across UK, Europe, And Asia Footprint

THE CBD world is set with a massive shake-up this week as Thought Leaders, the US cannabis & CBD investment company,...

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis...

European Cannabis Market Leader Bloomwell Group Secures $10m Investment

The Bloomwell Group has successfully closed a seed funding round of over $10 million dollars—the highest publicly known seed investment...

German Hemp Farm Numbers Up 900% In Seven Years – As industry Calls For Post-Election Reform

THE number of German farms growing industrial hemp has hit 863 – the highest figure since the federal republic...

US Company Set To Launch UK Medical Cannabis Study In Partnership With Manchester University

A GROUND-BREAKING human pilot study centred on the University of Manchester could provide answers to using cannabis as a...

Must read

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science,...

You might also likeRELATED
Recommended to you